Literature DB >> 18336930

Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy.

Stijn Stroobants1, Toon Leroy, Matthias Eckhardt, Jean-Marie Aerts, Daniel Berckmans, Rudi D'Hooge.   

Abstract

Arylsulfatase A (ASA)-deficient mice represent an animal model for the lysosomal storage disorder metachromatic leukodystrophy (MLD). Although the model has been applied in pathophysiological and therapeutic studies, the behavioural phenotype of ASA(-/-) mice is only partially characterized, and the most decisive outcome measures for therapy evaluation only emerge beyond 1 year of age. Presently, ASA(-/-) mice and ASA(+/-) control mice were studied at 6 and 12 months of age on an extensive battery including tests of neuromotor ability, exploratory behaviour, and learning and memory. Overt signs of ataxia were not observed in 6-month-old ASA(-/-) mice, but quantitative gait analysis during open-field exploration revealed that ASA(-/-) mice displayed increased hind base width and increased stride lengths for all paws. Their covert motor incoordination was evident in a correlation analysis which unveiled decreased harmonisation of concurrent gait parameters. For example, while ASA(+/-) controls demonstrated substantial convergence of front and hind base width (r=0.54), these variables actually diverged in ASA(-/-) mice (r=-0.37). Furthermore, various behavioural observations indicated emotional alterations in ASA(-/-) mice. Six-month-old ASA(-/-) mice also showed decreased response rates in scheduled operant responding. The present findings could provide relevant behavioural outcome measures for further use of this murine MLD model in preclinical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336930     DOI: 10.1016/j.bbr.2008.01.008

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Arylsulfatase A deficiency causes seminolipid accumulation and a lysosomal storage disorder in Sertoli cells.

Authors:  Hongbin Xu; Kessiri Kongmanas; Suraj Kadunganattil; Charles E Smith; Tony Rupar; Naoko Goto-Inoue; Louis Hermo; Kym F Faull; Nongnuj Tanphaichitr
Journal:  J Lipid Res       Date:  2011-10-02       Impact factor: 5.922

2.  Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.

Authors:  Markus Damme; Stijn Stroobants; Steven U Walkley; Renate Lüllmann-Rauch; Rudi D'Hooge; Jens Fogh; Paul Saftig; Torben Lübke; Judith Blanz
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

3.  Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy.

Authors:  Ulrich Matzner; Renate Lüllmann-Rauch; Stijn Stroobants; Claes Andersson; Cecilia Weigelt; Carl Eistrup; Jens Fogh; Rudi D'Hooge; Volkmar Gieselmann
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

4.  Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.

Authors:  Christof Trabszo; Bastian Ramms; Pradeep Chopra; Renate Lüllmann-Rauch; Stijn Stroobants; Jens Sproß; Anke Jeschke; Thorsten Schinke; Geert-Jan Boons; Jeffrey D Esko; Torben Lübke; Thomas Dierks
Journal:  Biochem J       Date:  2020-09-18       Impact factor: 3.857

Review 5.  The role and metabolism of sulfatide in the nervous system.

Authors:  Matthias Eckhardt
Journal:  Mol Neurobiol       Date:  2008-05-09       Impact factor: 5.590

6.  A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease.

Authors:  Heike Wolf; Markus Damme; Stijn Stroobants; Rudi D'Hooge; Hans Christian Beck; Irm Hermans-Borgmeyer; Renate Lüllmann-Rauch; Thomas Dierks; Torben Lübke
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

7.  Folic Acid Fortification Prevents Morphological and Behavioral Consequences of X-Ray Exposure During Neurulation.

Authors:  Kai Craenen; Mieke Verslegers; Zsuzsanna Callaerts-Vegh; Livine Craeghs; Jasmine Buset; Kristof Govaerts; Mieke Neefs; Willy Gsell; Sarah Baatout; Rudi D'Hooge; Uwe Himmelreich; Lieve Moons; Mohammed Abderrafi Benotmane
Journal:  Front Behav Neurosci       Date:  2021-01-08       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.